Growth hormone deficiency in children and adults is a disease state that utilizes growth hormone therapy. Here is what specialty pharmacists can do for these patients and what they should know about these conditions.
For US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.
Patient education and understanding the relationship between hyperglycemia, peripheral vascular disease, neuropathy, and foot complications are essential to reduce the potential for foot injury, ulceration, or amputation.
Specialty pharmacy is at the forefront of providing the team-based care and patient counseling now being sought in the developing accountable care organization model.
This month marks the 45th anniversary of the introduction of the pharmacy stamp. A collector of the commemorative envelopes of first-day covers ruminates on his hobby.
Total 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.
Data from large survey reports suggest that more than 80% of Americans who undergo surgery experience some level of postsurgical pain.
There are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
In an era of high-priced drugs, health care stakeholders continue to explore alternative pricing models that focus on the concept of value-based drug purchasing models.
The cost of oncology treatment is high and rising in the United States.
This close look at the top 200 drugs of 2010 by sales and prescriptions dispensed reveals the story of a pharmaceutical market in flux.
Discontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.
Knowing the warning signs and establishing trust are crucial to identifying and treating the opioid abuser.
The entrepreneurial pharmacist has the responsibility of creating the value proposition for providing medication reconciliation.
GPhA commends House Energy and Commerce Committee Chairman Fred Upton, Ranking Member Frank Pallone, Rep. Diana DeGette, Health Subcommittee Chair Joe Pitts, and Health Subcommittee Ranking Member Gene Green for their bipartisan leadership around fostering the development of new cures.
One of the most enduring lessons from my training in the care of geriatric patients is the following maxim: “Treat every new symptom like a (possible) drug adverse effect until proven otherwise.”
Oncology nurses help improve patient outcomes through their dedication and expertise.
This paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.
Knowledgeable pharmacists can positively influence mothers who are depressed as well as women who want to breast-feed but do not because of medication use.
While often overlooked, employee engagement is a key element in determining whether a hospital, health system, or pharmacy service can effectively meet its patient access, patient quality, and organizational financial demands.
A model of formulary decision making that evaluates medications based on usage could have significant implications for providers, consumers, and manufacturers.
Nearly 33% of adults in the United States have the typically symptomless disease known as hypertension.
This study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.